A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Hepatitis C Virus (HCV) Antibody Screen with Reflex to HCV RNA, PCR
Test CodeAlias/See Also
Preferred Specimen
Specimen Type: Serum
Collection Container: Serum gel
Specimen Volume: 3 mL
Minimum Volume
0.5 mL
Other Acceptable Specimens
Collection Container: Red top
Instructions
Transport Container
Specimen Stability
Room temperature: 3 days
Refrigerated: 7 days
Frozen: 1 month
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Unlabeled, mislabeled, wrong tube type, grossly hemolyzed, QNS, exceeds specimen/stability requirements.
Methodology
Chemiluminescent microparticle immunoassay
Setup Schedule
Daily
Report Available
Same day
Limitations
A non-reactive test does not exclude the possibility of exposure to hepatitis C virus.
Results obtained with this methodology cannot be used interchangeably with results from other methodologies.
Reactive anti-HCV does not exclude co-infection with other hepatitis viruses.
Heterophile antibodies, HAMA interfere with the methodology, and may cause false results.
Not intended for use in screening blood, plasma, or tissue donors.
Assay performance characteristics have not been established for newborns, infants, children, immunocompromised or immunosuppressed patients.
Reference Range
Clinical Significance
HCV antibody may not be detectable for up to 6 months following infection, but is usually always detected by late convalescent stage. Negative results should be evaluated cautiously with respect to clinical findings. When HCV infection is suspected, detection of HCV RNA by reverse transcriptase polymerase chain reaction provides the most sensitive and specific technique available for the direct detection of HCV in patient serum.
Performing Laboratory
Inova Laboratories
2832 Juniper Street
Fairfax, VA 22031
Last Updated: April 10, 2023
Last Review: N. Wolford, April 10, 2023